Anemia
Phase 3 study investigating the efficacy and safety of roxadustat for treatment of anemia in patients with lower risk Myelodysplastic Syndrome (MDS) and low Red Blood Cell (RBC) transfusion burden.
Phase 3 study investigating the efficacy and safety of roxadustat for treatment of anemia in patients with lower risk Myelodysplastic Syndrome (MDS) and low Red Blood Cell (RBC) transfusion burden.